Clinical Trial Update: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study [Phase 4]

View source ↗

Summary

A Phase 4 post-market clinical study evaluating Illumenate devices in below-the-knee arteries for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ILLUMENATE

Snippet

Sponsor: Spectranetics Corporation | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED